Jobs

Associate Director, Global Pricing and Access - ADD and Neurodegeneration Pipeline
Cambridge, MA
·
On-site
·
Full-time
·
1w ago
Compensation
$168,000 - $231,000
Benefits & Perks
•Healthcare
•Dental
•Vision
•Life Insurance
•Gym
•Disability Insurance
•Paid Time Off
•Parental Leave
•401(k)
•Equity
•Learning Budget
•Healthcare
•Gym
•Parental Leave
•401k
•Equity
•Learning
Required Skills
Pricing strategy
Market access
Payer engagement
Strategic planning
Communication
Stakeholder management
About This Role:
The Associate Director, Global Pricing and Access will spearhead the market access, payer evidence, and pricing strategies for our Alzheimer’s Disease and neurodegeneration portfolio. As a key member of the Global Pricing and Access team, you will be responsible for developing and executing value and access strategies, integrating these considerations into both development and commercialization phases. This role involves engaging with external stakeholders and potential collaborators, ensuring seamless negotiation strategies for reimbursement submissions, and fostering innovative access schemes. By developing evidence generation strategies, you will contribute significantly to the portfolio's success. Reporting directly to the Head of Global Pricing & Access, your role will be pivotal in shaping the future access landscape for our groundbreaking therapies.
What You’ll Do:
- Lead the strategic direction and daily execution of the Value and Access workstreams for the ADD portfolio.
- Provide strategic guidance to the product development and commercialization teams, influencing life cycle planning.
- Oversee the development of market access tools to secure pricing, reimbursement, and access for current and future products.
- Leverage interactions with regional and affiliate Market Access Networks to ensure coordinated global and regional strategies.
- Develop and communicate long-range Value and Access strategies and roadmaps for the portfolio.
- Represent the company at scientific and technical external events.
- Engage closely with internal teams to elevate market access acumen across the enterprise.
Who You Are:
You are a strategic thinker with a deep understanding of the global payer environment. Your ability to communicate complex ideas clearly and influence stakeholders is unmatched. You thrive in dynamic environments and are adept at balancing multiple priorities. Your collaborative spirit and capacity to engage with cross-functional teams make you a natural leader in market access strategy. Your passion for innovation drives you to seek creative solutions that enhance patient access to therapies.
Required Skills:
- Master’s or doctorate in a related economic, scientific, or business discipline.
- 7+ years of relevant pricing and access experience, including a strong understanding of the payer environment globally.
- Experience in developing global payer policy and strategies.
- Demonstrated expertise in pharmaceutical product development or commercialization.
- Strong communication and influencing skills.
- Ability to work effectively under pressure and within short timeframes.
Preferred Skills:
- Experience with innovative contracting proposals.
- Knowledge of health technologies assessment and health policy.
- Proven track record of developing therapeutic expertise.
Job Level: Management
Additional Information:
The base compensation range for this role is: $168,000.00-$231,000.00
Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.
In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families physical, financial, emotional, and social well-being; including, but not limited to:
- Medical, Dental, Vision, & Life insurances
- Fitness & Wellness programs including a fitness reimbursement
- Short- and Long-Term Disability insurance
- A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
- Up to 12 company paid holidays + 3 paid days off for Personal Significance
- 80 hours of sick time per calendar year
- Paid Maternity and Parental Leave benefit
- 401(k) program participation with company matched contributions
- Employee stock purchase plan
- Tuition reimbursement of up to $10,000 per calendar year
- Employee Resource Groups participation
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Total Views
0
Apply Clicks
0
Mock Applicants
0
Scraps
0
Similar Jobs

Director, Actuarial Analytics – Healthcare Utilization & Revenue Forecasting
Athenahealth · 6 Locations

Head of Japan Public Policy
Block (Square) · Tokyo, Japan

Head of Requirements and Capabilities
Collins Aerospace (RTX) · AU-ACT-CANBERRA-2613 ~ 4 Brindabella Cct ~ BRINDABELLA PARK, Lvl 1

Director, Services Portfolio Marketing
Ciena · Ottawa

Senior Commercial Account Executive
Zendesk · Manila, Philippines
About Biogen

Biogen
PublicSpecializing in the treatment of neurological diseases.
5,001-10,000
Employees
Cambridge
Headquarters
Reviews
4.1
47 reviews
Work Life Balance
3.6
Compensation
4.7
Culture
4.1
Career
4.4
Management
3.8
84%
Recommend to a Friend
Pros
Opportunities for continuous learning and growth
Strong engineering culture with focus on code quality
Cutting-edge technology stack and interesting technical challenges
Cons
Organizational changes and restructuring can be disruptive
Fast-paced environment with tight deadlines
Work-life balance can be challenging during product launches
Salary Ranges
541 data points
Mid/L4
Senior/L5
Mid/L4 · SR Analyst, R&D Business Ops
1 reports
$131,388
total / year
Base
$114,250
Stock
-
Bonus
-
$131,388
$131,388
Interview Experience
47 interviews
Difficulty
3.5
/ 5
Duration
14-28 weeks
Offer Rate
36%
Experience
Positive 65%
Neutral 25%
Negative 10%
Interview Process
1
Phone Screen
2
Technical Interview
3
System Design
4
Behavioral
5
Team Fit
Common Questions
Tell me about a challenging project
System design question
Coding problem
Why this company
News & Buzz
FDA grants breakthrough therapy designation to Biogen’s litifilimab - Investing.com
Source: Investing.com
News
·
5w ago
Biogen’s Litifilimab Receives FDA Breakthrough Therapy Designation for Cutaneous Lupus Erythematosus, a Disease With No Targeted Treatment Options - Biogen
Source: Biogen
News
·
5w ago
FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease under Priority Review - Biogen
Source: Biogen
News
·
5w ago
Biogen’s Alisha Alaimo On The Company’s Next Big Commercial Build - Citeline News & Insights
Source: Citeline News & Insights
News
·
6w ago